300463.SZ Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 10:04):

Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of IVD products and related services in China and internationally...

Stats
Šios dienos apimtis	7.66M
Vidutinė apimtis	5.91M
Rinkos kapitalizacija	7.97B
EPS	CNY0.153 ( 2023-10-25 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	25.27
ATR14	CNY0.0150 (0.11%)

Tūris Koreliacija

Ilgas: 0.13 (neutral)

Trumpas: 0.25 (neutral)

Signal:(51.158) Neutral

Maccura Biotechnology Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Maccura Biotechnology Koreliacija - Valiuta/Žaliavos

0.41
( neutral )

-0.72
( moderate negative )

0.00
( neutral )

0.20
( neutral )

-0.67
( moderate negative )

Maccura Biotechnology Finansinės ataskaitos

Annual	2023
Pajamos:	CNY2.90B
Bruto pelnas:	CNY1.60B (55.27 %)
EPS:	CNY0.510

FY	2023
Pajamos:	CNY2.90B
Bruto pelnas:	CNY1.60B (55.27 %)
EPS:	CNY0.510

FY	2022
Pajamos:	CNY3.61B
Bruto pelnas:	CNY1.96B (54.22 %)
EPS:	CNY1.170

FY	2021
Pajamos:	CNY3.98B
Bruto pelnas:	CNY2.31B (57.95 %)
EPS:	CNY1.731

Financial Reports:

No articles found.

Maccura Biotechnology

Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of IVD products and related services in China and internationally. The company offers immunoassay products, such as chemiluminescence analyzers and reagents; clinical chemistry reagents for hepatic function, glycometabolism, iron and other, renal function, coagulation, special protein, cardiac, and lipids; and clinical laboratory products, such as automatic hematology, and automatic and semi-automatic coagulation analyzers. It also provides SARS-COV-2(COVID-19) products that includes nucleic acid detection kit and other products; glucometers; POCT products, such as fluorescence immunoassay analyzers, as well as colloidal gold kits; molecular diagnosis products, such as PCR kit; and pathology products. The company was incorporated in 1994 and is based in Chengdu, China.